WASHINGTON — Autologous nonmyeloablative hematopoietic stem cell transplantation resulted in significant increases in C-peptide levels and insulin independence for an average of more than 2 years in 20 of 23 patients newly diagnosed with type 1 diabetes.
PREVIEW